Study: Statins could help critically ill patients avoid delirium
Delirium is a common issue for individuals who are cared for in intensive care units, and this condition could make the healing process strained.
Delirium is a common issue for individuals who are cared for in intensive care units, and this condition could make the healing process strained. This illness is described as a sudden and severe confusion brought on my rapidly changing brain function due to a physical or mental strain, according to the National Institutes of Health.
Although there are several Canadian drugs on the market that can help those who are critically ill stay healthy, a new study suggests that statins could help suppress the mechanism that causes delirium in the first place.
Details of the study
After following these patients from August 2011 to February 2012 and looking at markers for inflammation, the researchers determined that those who received statin treatment, such as medications like Vytorin, had a much lower risk for delirium the day after treatment.
"Our findings suggest that statin treatment should be continued to help prevent delirium in critically ill patients who received statins before being admitted," Page said in a news release from the American Thoracic Society.
Page went on to say that another study comparing patients who take an inactive placebo and people who are administered statin therapy could help reveal even more of a correlation between these drugs and markers for inflammation.
Delirium and critically ill patients
"This is important since it further confirms that delirium is a disease entity that has significant impact on clinical outcome," lead author Dr. Zhongheng Zhang, intensive care specialist at Jinhua Municipal Central Hospital in Zhejiang, China, explained in Science Daily.
Many people buy Vytorin to help reduce their levels of cholesterol, but statins such as these may bring effective treatment for ICU patients in the near future.